View all news

Sleep Number and American Cancer Society Form Long-Term Partnership to Study Impact of Quality Sleep on Cancer Prevention and Survivorship

02/02/2022

Organizations to conduct joint research with goal of developing sleep strategies and guidance for cancer patients and survivors, leading to improved quality of life

MINNEAPOLIS--(BUSINESS WIRE)-- In advance of World Cancer Day on Friday, February 4, Sleep Number Corporation (Nasdaq: SNBR) and the American Cancer Society (ACS) today announced a landmark partnership to embark upon foundational sleep research to inform the first-ever, cancer-specific sleep guidelines. Over the next six years, ACS will conduct research with contributions from Sleep Number’s proprietary sleep data and sleep expertise to identify the impact of quality sleep on cancer prevention and recovery, with the goal of improving sleep outcomes for cancer patients and survivors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220201006260/en/

In advance of World Cancer Day on Friday, February 4, Sleep Number Corporation (Nasdaq: SNBR) and the American Cancer Society (ACS) today announced a landmark partnership to embark upon foundational sleep research to inform the first-ever, cancer-specific sleep guidelines.

In advance of World Cancer Day on Friday, February 4, Sleep Number Corporation (Nasdaq: SNBR) and the American Cancer Society (ACS) today announced a landmark partnership to embark upon foundational sleep research to inform the first-ever, cancer-specific sleep guidelines.

While ACS offers guidance on healthy habits for people with cancer around things like diet, exercise, and tobacco, guidelines for sleep have not been established. There is limited knowledge of the biologic mechanisms by which sleep may affect cancer risk or outcomes after a cancer diagnosis, and while poor sleep quality may be associated with the risk of developing some types of cancer, evidence to date is limited. Leveraging the over 13 billion hours of highly-accurate sleep data generated from Sleep Number 360® smart beds in conjunction with historical and ongoing cancer prevention studies, ACS will study the effects of cancer on patients’ and survivors’ nighttime sleep and biometric patterns. The collaboration between the two organizations will enable cancer research and prevention tied explicitly to quality sleep.

In addition, Sleep Number recently announced their commitment to ACS’s Hope Lodge communities, which provide respite, shelter and care for cancer patients and caregivers. Sleep Number is providing sleep solutions to ensure Hope Lodge guests benefit from quality sleep to bolster their physical, mental, and emotional resilience.

“Our partnership with American Cancer Society directly supports our company’s purpose – to improve the health and wellbeing of society through higher quality sleep. We will utilize our 360 smart bed’s proprietary sleep data and sleep expertise, along with ACS’s tremendous body of research, to benefit cancer patients and survivors, and society at large,” said Shelly Ibach, President and CEO, Sleep Number. “Cancer is undiscriminating – it affects everyone. Sleep is also universal. Our hope is that sleep guidelines will help to eradicate this devastating disease and improve millions of lives. We are honored to join ACS in the fight for a world without cancer.”

The initial research will take place as part of an ongoing ACS cohort study, assessing individuals over the course of many years. Sleep Number’s contributions will enable targeted, cancer-related sleep science exploration, combining the magnitude of the ACS body of evidence regarding cancer prevention with the 360® smart bed’s highly accurate, longitudinal sleep data to meaningfully advance cancer-related sleep interventions.

“Sleep quality is a documented problem for cancer patients and longer term in cancer survivors, and the ability to formally study sleep’s impact on cancer has been limited. We plan to close that gap,” said Dr. Karen Knudsen, ACS Chief Executive Officer. "Through our partnership with Sleep Number, the ACS research team will more precisely measure the impact of sleep quality, with the potential of developing evidence-based sleep guidelines. As such, this research endeavor is fully aligned to our mission to improve the lives of cancer patients and their families."

About Sleep Number Corporation
Individuality is the foundation of Sleep Number. Our purpose driven company is comprised of over 5,000 passionate team members who are dedicated to our mission of improving lives by individualizing sleep experiences. We have improved almost 14 million lives and are positively impacting society’s wellbeing through higher quality sleep.

Our award-winning 360 smart beds are informed by science. They learn from over one billion sleep sessions of highly-accurate, real world sleep data – the cumulation of over 13 billion hours’ worth – to automatically adjust to each sleeper and provide effortless comfort and proven quality sleep. Our 360 smart beds deliver individualized sleep health reports and insights, including a daily SleepIQ® score, and are helping to advance meaningful sleep health solutions by applying sleep science and research.

For life-changing sleep, visit SleepNumber.com or one of our almost 650 Sleep Number® stores. More information is available on our newsroom and investor relations sites.

About The American Cancer Society
The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer. From breakthrough research, to free lodging near treatment, a 24/7/365 live helpline, free rides to treatment, and convening powerful activists to create awareness and impact, the Society is attacking cancer from every angle. For more information, visit cancer.org.

Forward-looking Statements
Statements used in this news release relating to future plans, events or performance such as plans to help identify the impact of quality sleep on cancer prevention and recovery are forward-looking statements subject to certain risks and uncertainties. Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

Julie Elepano
Sleep Number Public Relations
Julie.Elepano@sleepnumber.com

Nichole Teixeira
Sleep Number Public Relations
Nichole.Teixeira@sleepnumber.com

Source: Sleep Number Corporation

Multimedia Files:

Categories: Press Releases
View all news